Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRA | P25101 | 5/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.41 |
| ▸ | NAAA | Q02083 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | EDNRB | P24530 | 3/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1655802 | 1.00 | EDNRA (0.42) | EDNRAEPHX1NAAAHTTCYP2C19 | |
| SCHEMBL1656157 | 0.98 | EDNRA (0.43) | EDNRAEPHX1NAAAHTTCYP2C19 | |
| SCHEMBL1656158 | 0.98 | EDNRA (0.43) | EDNRAEPHX1NAAAHTTCYP2C19 | |
| SCHEMBL872686 | 0.86 | EPHX1 (0.44) | EPHX1NAAAHTTCYP2C19CA12 | |
| SCHEMBL20856638 | 0.86 | EPHX1 (0.44) | EPHX1NAAAHTTCYP2C19CA12 | |
| SCHEMBL19244484 | 0.86 | EPHX1 (0.44) | EPHX1NAAAHTTCYP2C19CA12 | |
| SCHEMBL872685 | 0.86 | EPHX1 (0.44) | EPHX1NAAAHTTCYP2C19CA12 | |
| SCHEMBL29256547 | 0.84 | EPHX1 (0.41) | EDNRAEPHX1NAAAHTTCYP2C19 | |
| SCHEMBL19244485 | 0.84 | EPHX1 (0.41) | EDNRAEPHX1NAAAHTTCYP2C19 | |
| SCHEMBL28553654 | 0.84 | EPHX1 (0.41) | EDNRAEPHX1NAAAHTTCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4239000-A1 | COMPOSITION FOR FORMING LOW DIELECTRIC CONSTANT RESIN, LOW DIELECTRIC MEMBER, AND ELECTRONIC DEVICE USING SAME | JNC Corporation (JP) | 2023-09-06 | — | — | EP | disclosed |
| CN-115989248-A | Composition for forming low dielectric constant resin, low dielectric member, and electronic device using the low dielectric member | 捷恩智株式会社 | 2023-04-18 | — | — | CN | disclosed |
| CN-115850580-A | Composition for forming low dielectric constant resin and use thereof | 捷恩智株式会社 | 2023-03-28 | — | — | CN | disclosed |
| WO-2022092063-A1 | COMPOSITION FOR FORMING LOW DIELECTRIC CONSTANT RESIN, LOW DIELECTRIC MEMBER, AND ELECTRONIC DEVICE USING SAME | JNC株式会社 | 2022-05-05 | — | — | WO | disclosed |
| US-8168734-B2 | Lateral alpha-substituted acrylate compound and polymer thereof | JNC CORPORATION (JP) | 2012-05-01 | — | — | US | disclosed |
| US-20110144293-A1 | LATERAL ALPHA-SUBSTITUTED ACRYLATE COMPOUND AND POLYMER THEREOF | CHISSO CORPORATION (JP) | 2011-06-16 | — | — | US | disclosed |
| US-7919648-B2 | Lateral α-substituted acrylate compound and polymer thereof | CHISSO CORPORATION (JP) | 2011-04-05 | — | — | US | disclosed |
| US-20070134447-A1 | Lateral a-substituted acrylate compound and polymer thereof | CHISSO CORPORATION | 2007-06-14 | — | — | US | disclosed |
| US-7157124-B2 | Polymerizable compounds and their polymers | CHISSO PETROCHEMICAL CORPORATION (JP) | 2007-01-02 | — | — | US | disclosed |
| US-7070838-B2 | Liquid crystalline compound, liquid crystal composition and their polymers | CHISSO PETROCHEMICAL CORPORATION (JP) | 2006-07-04 | — | — | US | disclosed |
| US-20050007541-A1 | Liquid crystalline compound, liquid crystal composition and their polymers | JNC PETROCHEMICAL CORPORATION (JP) | 2005-01-13 | — | — | US | disclosed |
| US-20040222403-A1 | Polymerizable compounds and their polymers | JNC PETROCHEMICAL CORPORATION (JP) | 2004-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144293-A1 | LATERAL ALPHA-SUBSTITUTED ACRYLATE COMPOUND AND POLYMER THEREOF | LEF1, AFF1, CNKSR1 | EDNRA 3085/4885EPHX1 4030/4885NAAA 3020/4885 |
| US-20070134447-A1 | Lateral a-substituted acrylate compound and polymer thereof | AFF1, CNKSR1, LEF1 | EDNRA 2412/4885EPHX1 4253/4885NAAA 2170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.